芍药苷
肝纤维化
肝星状细胞
下调和上调
血红素加氧酶
氧化应激
四氯化碳
纤维化
炎症
化学
羟脯氨酸
药理学
医学
四氯化碳
血红素
免疫学
内分泌学
内科学
生物化学
酶
高效液相色谱法
有机化学
基因
色谱法
作者
Ting Wang,Xu Zhou,Ge Kuang,Rong Jiang,Xinyi Guo,Shengwang Wu,Jingyuan Wan,Liangjun Yin
摘要
OBJECTIVES: The role of Paeoniflorin on hepatic fibrosis and the specific mechanisms has not yet been elucidated. Therefore, we explored whether Paeoniflorin exerted protective effects on carbon tetrachloride (CCl4)-induced hepatic fibrosis and the underlying mechanisms. METHODS: A model of hepatic fibrosis was induced by intraperitoneally injecting with CCl4 (10% 5 μl/g) twice a week for 7 weeks. To explore the effects of Paeoniflorin, mice were treated with Paeoniflorin (100 mg/kg) by gavage once a day at 1 week after modeling until they were sacrificed. KEY FINDINGS: Paeoniflorin remarkably improved liver function and histopathological changes of hepatic tissues in CCl4-induced liver injury. Besides, the serum MAO enzyme activity and hydroxyproline contents were notably decreased following the intervention of Paeoniflorin. The decreased expression of Vimentin, α-SMA, Col1a and Desmin manifested the inhibition of the hepatic stellate cells (HSCs) activation. Interestingly, Paeoniflorin intervention significantly upregulated the expression of heme oxygenase-1, and attenuated the inflammatory cytokines production as well as the CCl4-induced oxidative stress imbalance. CONCLUSIONS: Paeoniflorin could effectively alleviate CCl4-induced hepatic fibrosis by upregulation of heme oxygenase-1, and it might be a new effective option for the comprehensive treatment of hepatic fibrosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI